龍光集團(3380.HK)榮膺“2021中國城市更新卓越成就企業”
格隆匯9月11日丨中國房地產報主辦的“2021中國城市更新論壇”9月10日在深圳舉辦。龍光集團(3380.HK)持續鞏固“城市綜合服務商”定位,以城市更新賦能城市發展,榮膺“2021中國城市更新卓越成就企業”。龍光集團在粵港澳大灣區深耕近20年,在各城市擁有城市更新專業團隊,具有明顯的佈局優勢、品牌優勢、成本優勢。公司擁有持續的深耕及優秀的經營能力,已經打造了良好的品牌及口碑,城市更新業務保持良好發展勢頭。花旗、瑞銀、野村、平安證券等多家國內外大行一致認為,龍光集團城市更新業務具有差異化競爭優勢,目前主要位於粵港澳大灣區核心城市,轉化可持續,可保障公司長期穩健發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.